VALLEY FORGE, Pa.--(BUSINESS WIRE)--Nov. 12, 2002--
AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans
to issue $275 million Senior Notes due 2012. The notes will be issued
in a private placement and are expected to be resold by the initial
purchasers to qualified institutional buyers under Rule 144A of the
Securities Act of 1933. The proceeds from the sale of the notes will
be used to repay certain existing indebtedness.
The notes to be offered have not been registered under the
Securities Act of 1933 and may not be offered or sold in the United
States absent registration or an applicable exemption from
registration requirements. This news release shall not constitute an
offer to sell or a solicitation of an offer to buy such notes in any
jurisdiction in which such an offer or sale would be unlawful and is
issued pursuant to Rule 135-c under the Securities Act of 1933.
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical
services company in the United States dedicated solely to the
pharmaceutical supply chain. It is the leading distributor of
pharmaceutical products and services to the hospital systems/acute
care market, alternate care and mail order facilities, independent
community pharmacies, and regional chain pharmacies. The Company is
also a leader in the institutional pharmacy marketplace. With over $40
billion in annualized operating revenue, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs more than 13,000 people
serving over 25,000 customers. For more information go to
www.amerisourcebergen.com.
Forward Looking Statements
This press release may contain certain "forward-looking
statements" within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. These
statements are based on management's current expectations and are
subject to uncertainty and changes in circumstances. Actual results
may vary materially from the expectations contained in the
forward-looking statements. Forward-looking statements may include
statements addressing future financial and operating results of
AmerisourceBergen and the benefits and aspects of the 2001 merger
between AmeriSource Health Corporation and Bergen Brunswig
Corporation.
The following factors, among others, could cause actual results to
differ materially from those described in the forward-looking
statements: the risk that the businesses of AmeriSource and Bergen
Brunswig will not be integrated successfully; failure to obtain and
retain expected synergies; and other economic, business, competitive
and/or regulatory factors affecting the business of AmerisourceBergen
generally.
More detailed information about these factors is set forth in
AmerisourceBergen's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-K for fiscal 2001,
its Quarterly Reports on Form 10-Q for fiscal 2002, and the joint
proxy statement-prospectus for the merger filed on August 1, 2001.
AmerisourceBergen is under no obligation to (and expressly
disclaims any such obligation to) update or alter any forward-looking
statements whether as a result of new information, future events or
otherwise.
--30--des/ph*
CONTACT: |
AmerisourceBergen, Valley Forge |
---|
|
Michael N. Kilpatric, 610/727-7118 |
---|
|
[email protected] |
---|
|
---|
|
---|